Delivery Order SPE2DB20D3103-SPE2DB25FP9V5
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 50 mg capsules (120 count) at a firm fixed price of $13,836.26. This is a non-set-aside contract with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract valued at $8,896.41. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract valued at $27,672.52. This delivery order is expected to be completed by August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120 count) with a ceiling value of $8,896.41. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by September 12, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) valued at $8,896.41, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Tafinlar 75mg capsules (120 count) with a ceiling value of $35,585.68. This firm fixed-price delivery order, which is expected to be completed by September 26, 2025, represents a non-competitive set-aside award. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) with a ceiling value of $13,836.26. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) with a contract ceiling value of $8,896.42. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a purchase of pharmaceutical inventory supporting military and veteran...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,810 units of the pharmaceutical product Tafinlar 75 mg capsules. The order has an ultimate completion date of October 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a range...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,836.26 to AmerisourceBergen Drug Corp for the supply of Tafinlar 50 mg capsules (120 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...